These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 38114959)

  • 1. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.
    Dai L; Zhou P; Lyu L; Jiang S
    BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a cuproptosis-related prognostic model for glioblastoma.
    Zhang B; Xie L; Liu J; Liu A; He M
    Front Immunol; 2023; 14():1082974. PubMed ID: 36814929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics pan-cancer study of cuproptosis core gene
    Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
    Front Immunol; 2022; 13():981764. PubMed ID: 36605188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.
    Zhou Y; Xiao D; Jiang X; Nie C
    J Transl Med; 2023 Jan; 21(1):28. PubMed ID: 36647156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
    Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
    Front Genet; 2023; 14():1124439. PubMed ID: 36936439
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a prognostic model for glioblastoma multiforme based on the expression levels of efferocytosis-related genes.
    Xu W; Han L; Zhu P; Cheng Y; Chen X
    Aging (Albany NY); 2023 Dec; 15(24):15578-15598. PubMed ID: 38159261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer.
    Li J; Yu T; Sun J; Zeng Z; Liu Z; Ma M; Zheng Z; He Y; Kang W
    Aging (Albany NY); 2023 Apr; 15(7):2772-2796. PubMed ID: 37036489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis-related gene
    Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
    Front Immunol; 2022; 13():999823. PubMed ID: 36225932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
    Chen X; Hu G; Xiong L; Xu Q
    Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration.
    Yan T; Yang H; Meng Y; Li H; Jiang Q; Liu J; Xu C; Xue Y; Xu J; Song Y; Chu X; Wang L; Chen X; Che F
    Cancer Cell Int; 2023 May; 23(1):105. PubMed ID: 37246211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma.
    Li J; Song Z; Chen Z; Gu J; Cai Y; Zhang L; Wang Z
    J Mol Neurosci; 2024 Jan; 74(1):10. PubMed ID: 38214842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas.
    Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z
    Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.
    Liu R; Liu Y; Zhang F; Wei J; Wu L
    Front Immunol; 2023; 14():1146411. PubMed ID: 37063920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma.
    Feng J; Wang J; Xu Y; Lu F; Zhang J; Han X; Zhang C; Wang G
    PLoS One; 2023; 18(7):e0288180. PubMed ID: 37405988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cuproptosis-related gene signature to predict prognosis in Glioma.
    Zhang M; Liu X; Wang D; Ruan X; Wang P; Liu L; Xue Y
    BMC Cancer; 2023 Mar; 23(1):237. PubMed ID: 36915038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
    Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.